Chemical Structure (Buprenorphine 01)
Buprenorphine Tablet
Product Images NDC 72162-1344
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 72162-1344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Buprenorphine 02)
Label (Lbl721621344)
Identification: The tablet is debossed with "RP" on one side and "b2" on the other side.
Each sublingual tablet contains 2.16 mg of Buprenorphine HCI, which is equivalent to 2 mg of Buprenorphine.
It is important to keep this drug product out of reach of children, as accidental ingestion may require emergency medical care.
The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), according to USP Controlled Room Temperature guidelines.
When dispensing the medication, a Medication Guide should be provided to each patient.
For more information about the medication, please refer to the website: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=medguide.page
The tablets were manufactured by Purdue Pharma L.P.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
